Studying the molecular mechanism underlying the phosphorylation and activation of FAK in tumor cells and the accelerated disintegration of FAs is of great significance for a better understanding of the increased invasion and metastasis observed in PC and the development of possible therapeutic molecular targets for PC. The gene discussed is PTK2; the disease is pachyonychia congenita.